| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | YO029HR229 |
| InChI Key | MWXWMWSUUYXMRA-GRKBUMBKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C58H80N16O14 |
| Molecular Weight | 1225.38 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
RF amide receptor
|
36 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypogonadism | 2 | D007006 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1234319-68-6 |
| ChEMBL | CHEMBL3924151 |
| DrugBank | DB11975 |
| FDA SRS | YO029HR229 |
| Guide to Pharmacology | 10222 |
| PubChem | 46700761 |
| SureChEMBL | SCHEMBL12626550 |